232 related articles for article (PubMed ID: 20232358)
41. AP-1 activation and altered AP-1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells.
Berry A; Goodwin M; Moran CL; Chambers TC
Biochem Pharmacol; 2001 Sep; 62(5):581-91. PubMed ID: 11585055
[TBL] [Abstract][Full Text] [Related]
42. Two activator protein-1 elements in the matrix metalloproteinase-1 promoter have different effects on transcription and bind Jun D, c-Fos, and Fra-2.
White LA; Brinckerhoff CE
Matrix Biol; 1995 Dec; 14(9):715-25. PubMed ID: 8785586
[TBL] [Abstract][Full Text] [Related]
43. The possible separation of 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and hyperplasia by compound A.
Kowalczyk P; Kowalczyk MC; Junco JJ; Tolstykh O; Kinjo T; Truong H; Walaszek Z; Hanausek M; Slaga TJ
Mol Carcinog; 2013 Jun; 52(6):488-96. PubMed ID: 22351517
[TBL] [Abstract][Full Text] [Related]
44. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins.
Rutberg SE; Saez E; Glick A; Dlugosz AA; Spiegelman BM; Yuspa SH
Oncogene; 1996 Jul; 13(1):167-76. PubMed ID: 8700543
[TBL] [Abstract][Full Text] [Related]
45. Expression of epidermal ornithine decarboxylase and nuclear proto-oncogenes in phorbol ester tumor promotion-sensitive and -resistant mice.
Kennard MD; Kang DC; Montgomery RL; Butler AP
Mol Carcinog; 1995 Jan; 12(1):14-22. PubMed ID: 7818761
[TBL] [Abstract][Full Text] [Related]
46. SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB.
Gu Q; Bowden GT; Normolle D; Sun Y
J Cell Biol; 2007 Sep; 178(6):1009-23. PubMed ID: 17846172
[TBL] [Abstract][Full Text] [Related]
47. Regulation of the transcription factor AP-1 in benign and malignant mouse keratinocyte cells.
Joseloff E; Bowden GT
Mol Carcinog; 1997 Jan; 18(1):26-36. PubMed ID: 9022810
[TBL] [Abstract][Full Text] [Related]
48. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.
Gu Q; Tan M; Sun Y
Cancer Res; 2007 Apr; 67(8):3616-25. PubMed ID: 17440073
[TBL] [Abstract][Full Text] [Related]
49. Correlation between EGFR Y1068 tyrosine phosphorylation and AP-1 activation by tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin.
Cichocki M; Szamałek M; Dałek M; Baer-Dubowska W
Environ Toxicol Pharmacol; 2012 Jan; 33(1):92-7. PubMed ID: 22196048
[TBL] [Abstract][Full Text] [Related]
50. Multiple cis-elements mediate the transcriptional activation of human fra-1 by 12-O-tetradecanoylphorbol-13-acetate in bronchial epithelial cells.
Adiseshaiah P; Papaiahgari SR; Vuong H; Kalvakolanu DV; Reddy SP
J Biol Chem; 2003 Nov; 278(48):47423-33. PubMed ID: 13679379
[TBL] [Abstract][Full Text] [Related]
51. Okadaic acid stimulated TRE binding activity in a papilloma producing mouse keratinocyte cell line involves increased AP-1 expression.
Rosenberger SF; Bowden GT
Oncogene; 1996 Jun; 12(11):2301-8. PubMed ID: 8649769
[TBL] [Abstract][Full Text] [Related]
52. Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma.
Yang S; Meyskens FL
Mol Pharmacol; 2005 Jan; 67(1):298-308. PubMed ID: 15492115
[TBL] [Abstract][Full Text] [Related]
53. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract][Full Text] [Related]
54. 12-O-tetradecanoylphorbol-13-acetate--induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells.
Bernstein LR; Bravo R; Colburn NH
Mol Carcinog; 1992; 6(3):221-9. PubMed ID: 1445622
[TBL] [Abstract][Full Text] [Related]
55. Parathyroid hormone stimulates fra-2 expression in osteoblastic cells in vitro and in vivo.
McCauley LK; Koh-Paige AJ; Chen H; Chen C; Ontiveros C; Irwin R; McCabe LR
Endocrinology; 2001 May; 142(5):1975-81. PubMed ID: 11316763
[TBL] [Abstract][Full Text] [Related]
56. Sensitivity to tumor promotion of SENCAR and C57BL/6J mice correlates with oxidative events and DNA damage.
Wei L; Wei H; Frenkel K
Carcinogenesis; 1993 May; 14(5):841-7. PubMed ID: 8389253
[TBL] [Abstract][Full Text] [Related]
57. Expression of c-Fos and c-Jun in developing mouse lens.
Shirai K; Saika S; Okada Y; Senba E; Ohnishi Y
Ophthalmic Res; 2004; 36(4):226-30. PubMed ID: 15292661
[TBL] [Abstract][Full Text] [Related]
58. Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution.
Malnou CE; Brockly F; Favard C; Moquet-Torcy G; Piechaczyk M; Jariel-Encontre I
J Biol Chem; 2010 Feb; 285(9):6552-62. PubMed ID: 20053986
[TBL] [Abstract][Full Text] [Related]
59. Biphasic increase in c-jun mRNA is required for induction of AP-1-mediated gene transcription: differential effects of muscarinic and thrombin receptor activation.
Trejo J; Chambard JC; Karin M; Brown JH
Mol Cell Biol; 1992 Oct; 12(10):4742-50. PubMed ID: 1328861
[TBL] [Abstract][Full Text] [Related]
60. CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.
Miliani de Marval P; Lutfeali S; Jin JY; Leshin B; Selim MA; Zhang JY
Cancer Prev Res (Phila); 2011 Jun; 4(6):851-9. PubMed ID: 21478324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
